British Journal of Pharmacy (Nov 2016)

The Use of Inhalation Therapy in the Management of Chronic Obstructive Pulmonary Disease (COPD) in the Community: A Review of Studies

  • Farah Alhomoud

DOI
https://doi.org/10.5920/bjpharm.2016.14
Journal volume & issue
Vol. 1, no. 1

Abstract

Read online

Inhalation therapies are central to the management of chronic obstructive pulmonary disease (COPD). Although, findings from previous studies reveal suboptimal use and a wide range of problems with inhaler handling among COPD patients, very little is known about how and why problems arise. A systematic search of studies related to the topic area was conducted using Scopus and PubMed, from 2000 to 2013. As a result, twenty-two studies were included. Most studies had similar baseline characteristics. This review indicated that adherence to inhalation therapy was of concern. Rates of non-adherence to medication ranged from 29.5% to 80%. This review confirms non-adherence as a problem among patients and identifies factors which were potential contributors to medication non-adherence. The review reveals issues in operating the inhalation devices especially with the pressurised metered dose inhalers (pMDIs), which may lead to sub-optimal therapeutic outcomes and treatment failures.